Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
While the federal government is covering the cost of the COVID-19 vaccine for consumers during the public health emergency, some insurers may be left to foot the bill for providers’ time administering the shot. Although several insurers have said their members won’t be charged for the vaccine or its administration, some providers expect to shoulder ...
In the year 2020, the COVID-19 pandemic left many businesses in an unprecedented state of uncertainty. Healthcare companies across the care continuum had to face new unknown challenges, pushing them to rapidly learn, adapt and transform the way they deliver healthcare. As a result, the concept of “anytime anywhere care” has become mainstream, changing the rate at which we ...
The credit outlook for health insurers is stable for next year, though several trends to watch in 2021 could have a notable financial impact, according to a new report from Moody's Investors Service.
Telehealth advocates are homing in on the next big challenge to solidify virtual care’s gains during the COVID-19 pandemic: urging congressional action. “That’s really our No. 1 federal priority,” said Kyle Zebley, director of public policy at the American Telemedicine Association. The latest Medicare physician fee schedule, released earlier this week, offers a powerful step ...
UnitedHealth Group Inc. expects the pandemic to carve $2 billion out of its profits next year, with Covid-19 testing and treatment costs remaining steady even as more Americans return to their doctors’ offices for routine care.
Divided government in Washington threatens much of President-elect Joe Biden's legislative agenda, but prescription drug pricing is a rare area where he might find common ground with a Republican-controlled Senate.
A fiscally conservative group is putting six figures behind new digital ads aimed at sinking a measure to ban the “surprise” medical bills patients get from hospitals and services that aren’t covered by insurance.
The Trump administration is preparing to move forward with a major proposal to lower drug prices and rulemaking could come as soon as this week, according to people familiar with the effort.
The Trump administration is trying to overhaul some providers' payments for outpatient drugs in six weeks as it makes a last-ditch attempt to finalize drug-pricing policies that have languished in regulatory limbo.
The health care system could be “thrown into chaos” with “huge economic impacts” if the U.S. Supreme Court strikes down Obamacare, the program administrator in Nevada said.